1. Home
  2. TRT vs KYNB Comparison

TRT vs KYNB Comparison

Compare TRT & KYNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Trio-Tech International

TRT

Trio-Tech International

HOLD

Current Price

$5.80

Market Cap

35.1M

Sector

Technology

ML Signal

HOLD

KYNB

Kyntra Bio Inc. Common Stock

N/A

Current Price

$6.66

Market Cap

31.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TRT
KYNB
Founded
1958
1993
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
35.1M
31.9M
IPO Year
1995
N/A

Fundamental Metrics

Financial Performance
Metric
TRT
KYNB
Price
$5.80
$6.66
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
60.8K
30.7K
Earning Date
05-12-2026
03-16-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.02
N/A
Revenue
$32,462,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$305.50
$0.15
Revenue Growth
N/A
N/A
52 Week Low
$4.42
$6.54
52 Week High
$14.78
$9.58

Technical Indicators

Market Signals
Indicator
TRT
KYNB
Relative Strength Index (RSI) 51.12 39.61
Support Level $5.01 N/A
Resistance Level $6.48 $7.58
Average True Range (ATR) 0.51 0.37
MACD 0.05 -0.01
Stochastic Oscillator 44.03 23.89

Price Performance

Historical Comparison
TRT
KYNB

About TRT Trio-Tech International

Trio-Tech International operates in the semiconductor industry, providing manufacturing, testing, and distribution services for semiconductor test equipment and electronic components. It has two main segments: Semiconductor Back-end Solutions (SBS) and Industrial Electronics (IE). The SBS segment, which generates the majority of the Company's revenue, focuses on manufacturing equipment for semiconductor back-end processes, offering testing services, and distributing burn-in test related equipment. The IE segment manufactures equipment for other industries and distributes electronic products outside the semiconductor sector. The Company operates in the United States, Singapore, Malaysia, Thailand, and China, serving customers across multiple regions.

About KYNB Kyntra Bio Inc. Common Stock

Kyntra Bio Inc is a biopharmaceutical company focused on the development of novel therapies in oncology and rare disease. The company's research programs target cancer and rare disease indications, including anemia associated with lower-risk myelodysplastic syndrome (LR-MDS) and metastatic castration-resistant prostate cancer (mCRPC). Itd pipeline drug candidates include Roxadustat and FG-3246.

Share on Social Networks: